Literature DB >> 20348933

Medically important bacterial-fungal interactions.

Anton Y Peleg1, Deborah A Hogan, Eleftherios Mylonakis.   

Abstract

Whether it is in the setting of disease or in a healthy state, the human body contains a diverse range of microorganisms, including bacteria and fungi. The interactions between these taxonomically diverse microorganisms are highly dynamic and dependent on a multitude of microorganism and host factors. Human disease can develop from an imbalance between commensal bacteria and fungi or from invasion of particular host niches by opportunistic bacterial and fungal pathogens. This Review describes the clinical and molecular characteristics of bacterial-fungal interactions that are relevant to human disease.

Entities:  

Mesh:

Year:  2010        PMID: 20348933     DOI: 10.1038/nrmicro2313

Source DB:  PubMed          Journal:  Nat Rev Microbiol        ISSN: 1740-1526            Impact factor:   60.633


  94 in total

1.  Increased susceptibility to lethal Candida infections in burned mice preinfected with Pseudomonas aeruginosa or pretreated with proteolytic enzymes.

Authors:  A N Neely; E J Law; I A Holder
Journal:  Infect Immun       Date:  1986-04       Impact factor: 3.441

2.  Effect of pH on an in vitro model of gastric microbiota in enteral nutrition patients.

Authors:  Graeme A O'May; Nigel Reynolds; George T Macfarlane
Journal:  Appl Environ Microbiol       Date:  2005-08       Impact factor: 4.792

3.  Bacterial and fungal colonization of burn wounds.

Authors:  Jefferson Lessa Soares de Macedo; João Barberino Santos
Journal:  Mem Inst Oswaldo Cruz       Date:  2005-09-15       Impact factor: 2.743

4.  Effect of farnesol on Staphylococcus aureus biofilm formation and antimicrobial susceptibility.

Authors:  M A Jabra-Rizk; T F Meiller; C E James; M E Shirtliff
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

5.  Caenorhabditis elegans is a model host for Salmonella typhimurium.

Authors:  A Labrousse; S Chauvet; C Couillault; C L Kurz; J J Ewbank
Journal:  Curr Biol       Date:  2000-11-30       Impact factor: 10.834

6.  Candida sepsis. Implications of polymicrobial blood-borne infection.

Authors:  D L Dyess; R N Garrison; D E Fry
Journal:  Arch Surg       Date:  1985-03

7.  Effect of Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 on the ability of Candida albicans to infect cells and induce inflammation.

Authors:  Rafael C R Martinez; Shannon L Seney; Kelly L Summers; Auro Nomizo; Elaine C P De Martinis; Gregor Reid
Journal:  Microbiol Immunol       Date:  2009-09       Impact factor: 1.955

8.  Pseudomonas-Candida interactions: an ecological role for virulence factors.

Authors:  Deborah A Hogan; Roberto Kolter
Journal:  Science       Date:  2002-06-21       Impact factor: 47.728

9.  Vaginal IL-8 levels are positively associated with Candida albicans and inversely with lactobacilli in HIV-infected women.

Authors:  Gregory T Spear; M Reza Zariffard; Mardge H Cohen; Beverly E Sha
Journal:  J Reprod Immunol       Date:  2008-02-19       Impact factor: 4.054

10.  Discerning the complexity of community interactions using a Drosophila model of polymicrobial infections.

Authors:  Christopher D Sibley; Kangmin Duan; Carrie Fischer; Michael D Parkins; Douglas G Storey; Harvey R Rabin; Michael G Surette
Journal:  PLoS Pathog       Date:  2008-10-24       Impact factor: 6.823

View more
  185 in total

Review 1.  Bacterial-fungal interactions: hyphens between agricultural, clinical, environmental, and food microbiologists.

Authors:  P Frey-Klett; P Burlinson; A Deveau; M Barret; M Tarkka; A Sarniguet
Journal:  Microbiol Mol Biol Rev       Date:  2011-12       Impact factor: 11.056

Review 2.  Candida peritonitis: an update on the latest research and treatments.

Authors:  Herman Anthony Carneiro; Anastasios Mavrakis; Eleftherios Mylonakis
Journal:  World J Surg       Date:  2011-12       Impact factor: 3.352

3.  Candida colonization in ventilated ICU patients: no longer a bystander!

Authors:  Jean-Damien Ricard; Damien Roux
Journal:  Intensive Care Med       Date:  2012-06-15       Impact factor: 17.440

4.  Genetic control of Candida albicans biofilm development.

Authors:  Jonathan S Finkel; Aaron P Mitchell
Journal:  Nat Rev Microbiol       Date:  2010-12-29       Impact factor: 60.633

5.  Killing of Candida albicans filaments by Salmonella enterica serovar Typhimurium is mediated by sopB effectors, parts of a type III secretion system.

Authors:  Younghoon Kim; Eleftherios Mylonakis
Journal:  Eukaryot Cell       Date:  2011-04-15

6.  Cholic Acid-Peptide Conjugates as Potent Antimicrobials against Interkingdom Polymicrobial Biofilms.

Authors:  Siddhi Gupta; Jyoti Thakur; Sanjay Pal; Ragini Gupta; Deepakkumar Mishra; Sandeep Kumar; Kavita Yadav; Amandeep Saini; Prabhu S Yavvari; Madhukar Vedantham; Archana Singh; Aasheesh Srivastava; Rajendra Prasad; Avinash Bajaj
Journal:  Antimicrob Agents Chemother       Date:  2019-10-22       Impact factor: 5.191

7.  Virulence Factors in Candida albicans and Streptococcus mutans Biofilms Mediated by Farnesol.

Authors:  Renan Aparecido Fernandes; Douglas Roberto Monteiro; Laís Salomão Arias; Gabriela Lopes Fernandes; Alberto Carlos Botazzo Delbem; Debora Barros Barbosa
Journal:  Indian J Microbiol       Date:  2018-02-22       Impact factor: 2.461

8.  Symbiotic relationship between Streptococcus mutans and Candida albicans synergizes virulence of plaque biofilms in vivo.

Authors:  Megan L Falsetta; Marlise I Klein; Punsiri M Colonne; Kathleen Scott-Anne; Stacy Gregoire; Chia-Hua Pai; Mireya Gonzalez-Begne; Gene Watson; Damian J Krysan; William H Bowen; Hyun Koo
Journal:  Infect Immun       Date:  2014-02-24       Impact factor: 3.441

9.  Copsin, a novel peptide-based fungal antibiotic interfering with the peptidoglycan synthesis.

Authors:  Andreas Essig; Daniela Hofmann; Daniela Münch; Savitha Gayathri; Markus Künzler; Pauli T Kallio; Hans-Georg Sahl; Gerhard Wider; Tanja Schneider; Markus Aebi
Journal:  J Biol Chem       Date:  2014-10-23       Impact factor: 5.157

10.  Pseudomonas aeruginosa Inhibits the Growth of Scedosporium and Lomentospora In Vitro.

Authors:  Sharon C-A Chen; Shilpa Patel; Wieland Meyer; Belinda Chapman; Hong Yu; Karen Byth; Peter G Middleton; Helena Nevalainen; Tania C Sorrell
Journal:  Mycopathologia       Date:  2017-05-16       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.